Navigation Links
Grupo Casa Saba Announces 3Q09 Earnings Report
Date:10/28/2009

Cash and cash equivalents at the end of the third quarter of 2009 was $161.17 million, a decline of 44.99% compared to the same period of 2008.

COMPREHENSIVE COST OF FINANCING

During the period, GCS's comprehensive cost of financing (CCF) reached $47.71 million, 22.15% lower than the CCF reported during 3Q08. This was primarily due to a reduction in the amount of interest income paid as well as a lower exchange rate loss.

These interest payments are related to the long-term credit that was obtained as a result of the acquisition in Brazil as well as the interest that was generated from the utilization of short-term credits for our operations in both Mexico and Brazil.

OTHER EXPENSES (INCOME)

During the third quarter of 2009, the Company registered an income of $17.43 million in other expenses (income), an increase of 20.59% versus the same period of 2008. The expenses (income) from this line item were derived from activities that are distinct from the company's everyday business operations.

TAX PROVISIONS

During the third quarter, tax provisions were $24.74 million, 61.14% less than the $63.67 million obtained during 3Q08. Of these, $75.89 million were related to income tax payments and ($51.15) million were attributed to deferred income tax.

The effective tax rate for the quarter was 13.74%.

NET INCOME

As a result, GCS's net income for the third quarter was $155.38 million, an increase of 39.03% compared to the third quarter of 2008. The growth was primarily due to the reduction in both the CCF as well as the tax provisions. Consequently, the net margin for the period was 2.22%, 55 basis points higher than the 1.67% net margin registered during the third quarter of 2008.

WORKING CAPITAL

During the third quarter of 2009, our accounts receivable days increase
'/>"/>

SOURCE Grupo Casa Saba
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009
2. BioMarin Announces Third Quarter 2009 Financial Results
3. Rigel Announces Presentations at Two Investor Conferences
4. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
5. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
6. CardioGenics Holdings Inc. Announces Letter to Shareholders
7. Heska Announces Q309 Results
8. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
9. Inverness Medical Innovations Announces Third Quarter 2009 Results
10. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
11. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT(Nas...,theCompany,sPresidentandCEO,andKeithSchneck,theCo...presentatthe21stAnnualPiperJaffrayHealthCareConfer...rk. ,, Interestedpartiesmayaccessthepresentatio...ww.ert.com .Thewebcastmayalsobeaccessedat http://w...
(Date:11/25/2009)...EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGro...elara report,thefirstinamulti-phasesyndicatedmark...Biotech,sStelara,fromproductlaunchthroughthefirsts...quantitativeinformationfrom75uniqueDermatologistsa...assesstrialanduseofStelara,obstaclestouse,typicalp...
(Date:11/25/2009)...WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/--F...ciallythe27millionlivingwithuntreated hearingloss ...ndyBeyer. ,, Dr.Beyer,seniorvicepresidentofHear...d hearingaids companies,saidstudieshavelinkedheari...chcaneasilybeintensifiedatholidaygatheringswithfam...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 1Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 3Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 4Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 5Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 6Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 7Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 8MedCath Corporation Reports Fourth Quarter Earnings 6187 1MedCath Corporation Reports Fourth Quarter Earnings 6187 2MedCath Corporation Reports Fourth Quarter Earnings 6187 3MedCath Corporation Reports Fourth Quarter Earnings 6187 4MedCath Corporation Reports Fourth Quarter Earnings 6187 5MedCath Corporation Reports Fourth Quarter Earnings 6187 6MedCath Corporation Reports Fourth Quarter Earnings 6187 7MedCath Corporation Reports Fourth Quarter Earnings 6187 8MedCath Corporation Reports Fourth Quarter Earnings 6187 9MedCath Corporation Reports Fourth Quarter Earnings 6187 10MedCath Corporation Reports Fourth Quarter Earnings 6187 11MedCath Corporation Reports Fourth Quarter Earnings 6187 12MedCath Corporation Reports Fourth Quarter Earnings 6187 13MedCath Corporation Reports Fourth Quarter Earnings 6187 14MedCath Corporation Reports Fourth Quarter Earnings 6187 15MedCath Corporation Reports Fourth Quarter Earnings 6187 16MedCath Corporation Reports Fourth Quarter Earnings 6187 17MedCath Corporation Reports Fourth Quarter Earnings 6187 18MedCath Corporation Reports Fourth Quarter Earnings 6187 19Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 1Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 2Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 3Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 4
(Date:11/25/2009)... Nationwide Imaging Services, known as one of th...nostic imaging equipment, now offering a total sol...g options, service and installation with acquisiti...nologies of California) , ... Imaging Services is proud to announce its acquisi...
(Date:11/25/2009)... BioSpace.com, the premier resource for life sci...dition of the BioForest™ Hotbed Campaign thi...O (Vocus) November 25, 2009 -- BioSpace.com, the p...mation, unveiled the third edition of the BioFores...is regional campaign is a promotional effort highl...
(Date:11/25/2009)...ertoShareRecordsSafely,ImproveCare ,, WASHING...VeteransAffairs(VA)andKaiserPermanentetodayannounc...stoourNation,sheroes.VAandKaiserPermanentearelaunc...EHR)informationusingtheNationwideHealthInformation...nServices. ,, "Theabilitytosharecriticalhealthi...
(Date:11/25/2009)...v.25/PRNewswire/--dazzlesmile,llc www.dazzlesmile....cience.com havefileda67-pagefederallawsuitagainstE...seWillms,FarendServicesLimited,andAtLastFulfillmen...trictCourtfortheDistrictofUtah,allegesmassivenatio...andedteethwhiteningproducts,violationsoftheRackete...
(Date:11/25/2009)...ov.25/PRNewswire/--DanielTouizer,CEOof Ci n e ...healthinsurancebenefitprograms,isconcernedthatthel...lyoneinfiveAmericansarewithoutafull-timejobandunli...ratesaredeterminedbytheU-6number,whichhasspikedto1... T ouizer ."Thesestatisticsarealarmingasitmeans...
Breaking Medicine News(10 mins):Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2
...untain of Life is excited to announce that the Dav...ip product, VaNu. , , "Golfers drinking VaNu r... focus, better health, and an improved sense of we...ately became interested in the beverage after lear...
...los Endoscopy, Inc. (Pink Sheets: SNDY) is pleased...roduct line, the MammoView(TM), was featured in t...agazine in the December 2008 issue. The article fo...w(TM) product line employs advanced microendoscope...
...loped for assay kits from Beacon Analytical System...oplate readers with SoftMax(R), Pro analytical ...FirstCall/ - MDS Analytical Technologies, a leader...nalytical Systems, which focuses on the developmen...
... 19 The Providence Service Corporation (Nasdaq: ... has been awarded a $1.5 million annual contract t...ess center in Orange County, California. The cont...ed delivery model is very much aligned with Orange...
...f., Feb. 19 Based on its recent analysis of the N...p; Sullivan recognizes Horphag Research Ltd. with ...lence in Research of the Year Award. The award ack...ingredient, Pycnogenol(R), across industries such ...
...., Feb. 19 Smith & Nephew,s Advanced Wound Ma...d that the United States Patent and Trademark Offi...ree of KCI,s negative pressure wound therapy (NPWT...re-examined claims are not patentable, including t...
Other Medicine News:Health News:World-Renowned Golf Instructor David Leadbetter Promotes VaNu 2Health News:Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 3Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 4Health News:Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act 2Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 2Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 3Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 4Health News:United States Patent Office Rejects KCI's Patents 2Health News:United States Patent Office Rejects KCI's Patents 3
Neuropack MEB-7102 Evoked Potential Measuring System
Neuropack MEB-2200 Evoked Potential/EMG Measuring System
Myoquick 1200/1400/1800
Sierra Wave
Medicine Products: